Ultragenyx Stock Based Compensation vs Exchange Rate Changes Analysis

RARE Stock

USD 40.00 0.85 2.08%

Ultragenyx financial indicator trend analysis is much more than just breaking down Ultragenyx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ultragenyx is a good investment. Please check the relationship between Ultragenyx Stock Based Compensation and its Exchange Rate Changes accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Stock Based Compensation vs Exchange Rate Changes

Stock Based Compensation vs Exchange Rate Changes Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ultragenyx Stock Based Compensation account and Exchange Rate Changes. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Ultragenyx's Stock Based Compensation and Exchange Rate Changes is 0.9. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Exchange Rate Changes in the same time period over historical financial statements of Ultragenyx, assuming nothing else is changed. The correlation between historical values of Ultragenyx's Stock Based Compensation and Exchange Rate Changes is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Ultragenyx are associated (or correlated) with its Exchange Rate Changes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Exchange Rate Changes has no effect on the direction of Stock Based Compensation i.e., Ultragenyx's Stock Based Compensation and Exchange Rate Changes go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Exchange Rate Changes

The impact of changes in foreign exchange rates on a company's financial position and results.

Most indicators from Ultragenyx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ultragenyx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.The current year's Selling General Administrative is expected to grow to about 374.1 M, whereas Tax Provision is projected to grow to (2 M).

	2022	2023	2024	2025 (projected)
Reconciled Depreciation	18.2M	26.0M	29.9M	16.3M
Interest Income	11.1M	26.7M	30.7M	32.2M

Reconciled Depreciation Interest Income

Ultragenyx fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Short Term Investments
Total Assets		0.93	0.94	0.66	0.86	0.87	-0.64	-0.92	0.83	0.71	0.93	0.43	0.88	0.88	0.82	0.89	0.91	0.87	0.9	0.97	0.89	0.85	0.9	0.89	0.85	0.89
Other Current Liab	0.93		1.0	0.35	0.97	0.98	-0.36	-0.98	0.97	0.46	0.98	0.61	0.93	0.65	0.95	0.78	0.87	0.97	0.75	0.98	0.98	0.97	0.7	0.82	0.97	0.74
Total Current Liabilities	0.94	1.0		0.37	0.97	0.98	-0.38	-0.98	0.97	0.47	0.98	0.61	0.94	0.67	0.94	0.78	0.87	0.97	0.77	0.98	0.98	0.97	0.72	0.82	0.97	0.76
Total Stockholder Equity	0.66	0.35	0.37		0.19	0.22	-0.86	-0.37	0.16	0.84	0.4	-0.17	0.37	0.87	0.18	0.68	0.53	0.21	0.71	0.5	0.25	0.18	0.82	0.6	0.17	0.69
Other Liab	0.86	0.97	0.97	0.19		0.99	-0.25	-0.95	0.98	0.36	0.95	0.68	0.9	0.56	0.96	0.68	0.81	1.0	0.67	0.93	1.0	0.99	0.62	0.73	0.99	0.69
Property Plant And Equipment Net	0.87	0.98	0.98	0.22	0.99		-0.23	-0.96	0.98	0.34	0.97	0.68	0.95	0.57	0.95	0.7	0.82	0.99	0.7	0.94	0.99	1.0	0.61	0.75	1.0	0.7
Net Debt	-0.64	-0.36	-0.38	-0.86	-0.25	-0.23		0.36	-0.16	-0.99	-0.36	0.15	-0.27	-0.81	-0.24	-0.57	-0.5	-0.27	-0.61	-0.47	-0.3	-0.19	-0.83	-0.53	-0.18	-0.56
Retained Earnings	-0.92	-0.98	-0.98	-0.37	-0.95	-0.96	0.36		-0.95	-0.46	-0.97	-0.61	-0.93	-0.69	-0.92	-0.83	-0.92	-0.96	-0.82	-0.97	-0.97	-0.95	-0.73	-0.87	-0.96	-0.78
Accounts Payable	0.83	0.97	0.97	0.16	0.98	0.98	-0.16	-0.95		0.26	0.94	0.69	0.89	0.51	0.95	0.7	0.8	0.98	0.67	0.92	0.98	0.98	0.57	0.75	0.99	0.68
Cash	0.71	0.46	0.47	0.84	0.36	0.34	-0.99	-0.46	0.26		0.46	-0.06	0.37	0.85	0.34	0.64	0.59	0.38	0.66	0.56	0.4	0.29	0.87	0.6	0.29	0.61
Non Current Assets Total	0.93	0.98	0.98	0.4	0.95	0.97	-0.36	-0.97	0.94	0.46		0.66	0.96	0.68	0.93	0.79	0.88	0.95	0.8	0.98	0.96	0.96	0.71	0.82	0.96	0.75
Non Currrent Assets Other	0.43	0.61	0.61	-0.17	0.68	0.68	0.15	-0.61	0.69	-0.06	0.66		0.59	0.03	0.74	0.27	0.43	0.68	0.24	0.56	0.67	0.7	0.1	0.35	0.69	0.23
Other Assets	0.88	0.93	0.94	0.37	0.9	0.95	-0.27	-0.93	0.89	0.37	0.96	0.59		0.66	0.86	0.74	0.84	0.9	0.78	0.92	0.92	0.95	0.65	0.77	0.93	0.73
Cash And Short Term Investments	0.88	0.65	0.67	0.87	0.56	0.57	-0.81	-0.69	0.51	0.85	0.68	0.03	0.66		0.47	0.87	0.81	0.57	0.91	0.75	0.6	0.53	0.98	0.82	0.53	0.91
Net Receivables	0.82	0.95	0.94	0.18	0.96	0.95	-0.24	-0.92	0.95	0.34	0.93	0.74	0.86	0.47		0.65	0.77	0.96	0.59	0.92	0.96	0.96	0.55	0.71	0.96	0.58
Common Stock Total Equity	0.89	0.78	0.78	0.68	0.68	0.7	-0.57	-0.83	0.7	0.64	0.79	0.27	0.74	0.87	0.65		0.95	0.69	0.93	0.85	0.71	0.67	0.9	0.99	0.68	0.9
Common Stock Shares Outstanding	0.91	0.87	0.87	0.53	0.81	0.82	-0.5	-0.92	0.8	0.59	0.88	0.43	0.84	0.81	0.77	0.95		0.81	0.93	0.91	0.83	0.8	0.86	0.97	0.81	0.86
Non Current Liabilities Total	0.87	0.97	0.97	0.21	1.0	0.99	-0.27	-0.96	0.98	0.38	0.95	0.68	0.9	0.57	0.96	0.69	0.81		0.68	0.93	1.0	0.99	0.63	0.74	0.99	0.69
Other Current Assets	0.9	0.75	0.77	0.71	0.67	0.7	-0.61	-0.82	0.67	0.66	0.8	0.24	0.78	0.91	0.59	0.93	0.93	0.68		0.84	0.71	0.67	0.9	0.9	0.67	0.91
Other Stockholder Equity	0.97	0.98	0.98	0.5	0.93	0.94	-0.47	-0.97	0.92	0.56	0.98	0.56	0.92	0.75	0.92	0.85	0.91	0.93	0.84		0.95	0.93	0.79	0.87	0.93	0.81
Total Liab	0.89	0.98	0.98	0.25	1.0	0.99	-0.3	-0.97	0.98	0.4	0.96	0.67	0.92	0.6	0.96	0.71	0.83	1.0	0.71	0.95		0.99	0.65	0.76	0.99	0.71
Property Plant And Equipment Gross	0.85	0.97	0.97	0.18	0.99	1.0	-0.19	-0.95	0.98	0.29	0.96	0.7	0.95	0.53	0.96	0.67	0.8	0.99	0.67	0.93	0.99		0.58	0.73	1.0	0.67
Total Current Assets	0.9	0.7	0.72	0.82	0.62	0.61	-0.83	-0.73	0.57	0.87	0.71	0.1	0.65	0.98	0.55	0.9	0.86	0.63	0.9	0.79	0.65	0.58		0.87	0.58	0.91
Common Stock	0.89	0.82	0.82	0.6	0.73	0.75	-0.53	-0.87	0.75	0.6	0.82	0.35	0.77	0.82	0.71	0.99	0.97	0.74	0.9	0.87	0.76	0.73	0.87		0.73	0.87
Property Plant Equipment	0.85	0.97	0.97	0.17	0.99	1.0	-0.18	-0.96	0.99	0.29	0.96	0.69	0.93	0.53	0.96	0.68	0.81	0.99	0.67	0.93	0.99	1.0	0.58	0.73		0.68
Short Term Investments	0.89	0.74	0.76	0.69	0.69	0.7	-0.56	-0.78	0.68	0.61	0.75	0.23	0.73	0.91	0.58	0.9	0.86	0.69	0.91	0.81	0.71	0.67	0.91	0.87	0.68

Click cells to compare fundamentals

Ultragenyx Account Relationship Matchups

Ultragenyx fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.8B	1.5B	1.5B	1.5B	1.7B	1.8B
Other Current Liab	140.9M	134.5M	192.9M	225.7M	259.6M	272.6M
Total Current Liabilities	189.6M	181.4M	261.2M	280.4M	322.5M	338.6M
Total Stockholder Equity	1.2B	922.6M	352.5M	275.4M	316.7M	481.1M
Other Liab	348.7M	376.3M	387.6M	911.9M	1.0B	1.1B
Property Plant And Equipment Net	114.0M	176.2M	285.7M	290.6M	334.2M	350.9M
Net Debt	(665.3M)	(265.6M)	(101.4M)	(170.4M)	(153.4M)	(161.0M)
Retained Earnings	(1.6B)	(2.1B)	(2.8B)	(3.4B)	(3.0B)	(2.9B)
Accounts Payable	12.9M	17.1M	43.3M	42.1M	48.4M	50.9M
Cash	713.5M	307.6M	132.9M	213.6M	245.6M	202.9M
Non Current Assets Total	464.3M	665.8M	661.5M	758.8M	872.7M	916.3M
Non Currrent Assets Other	(24.5M)	11.6M	10.7M	57.7M	66.3M	69.7M
Other Assets	3.5M	8.8M	20.6M	16.8M	19.4M	20.3M
Cash And Short Term Investments	1.2B	999.1M	896.7M	577.2M	663.8M	543.4M
Net Receivables	23.1M	28.4M	40.4M	73.4M	84.4M	88.6M
Common Stock Total Equity	58K	67K	69K	70K	80.5K	44.1K
Common Stock Shares Outstanding	60.8M	67.8M	69.9M	73.5M	84.6M	50.9M
Liabilities And Stockholders Equity	1.8B	1.5B	1.5B	1.5B	1.7B	1.8B
Non Current Liabilities Total	415.6M	418.5M	931.7M	935.2M	1.1B	1.1B
Other Current Assets	57.6M	71.7M	68.9M	47.6M	54.8M	34.5M
Other Stockholder Equity	2.8B	3.0B	3.1B	3.7B	4.2B	4.4B
Total Liab	605.2M	599.8M	1.2B	1.2B	1.4B	1.5B
Property Plant And Equipment Gross	114.0M	226.2M	349.1M	374.0M	430.1M	451.6M
Total Current Assets	1.3B	856.6M	883.9M	732.2M	842.0M	564.7M
Accumulated Other Comprehensive Income	689K	(1.4M)	(6.6M)	647K	582.3K	611.4K
Common Stock	67K	69K	70K	82K	94.3K	47.6K
Property Plant Equipment	74.7M	73.5M	141.2M	259.7M	298.7M	313.6M
Short Term Investments	488.0M	432.6M	614.8M	363.6M	418.2M	347.3M
Net Tangible Assets	480.4M	978.9M	758.4M	148.0M	170.2M	161.7M
Retained Earnings Total Equity	(1.4B)	(1.6B)	(2.1B)	(2.8B)	(2.5B)	(2.4B)
Capital Surpluse	2.1B	2.8B	3.0B	3.1B	3.6B	2.0B
Inventory	13.0M	16.2M	26.8M	34.0M	39.1M	41.0M
Non Current Liabilities Other	382.3M	385.2M	4.8M	12.2M	14.0M	13.3M
Intangible Assets	131.1M	130.8M	160.1M	166.3M	191.2M	108.7M
Long Term Investments	10.5M	258.9M	154.5M	199.9M	229.9M	241.4M
Net Invested Capital	1.2B	922.6M	352.5M	275.4M	247.9M	235.5M
Net Working Capital	1.1B	675.2M	622.7M	451.7M	519.5M	667.7M
Capital Stock	67K	69K	70K	82K	94.3K	72.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:

How To Invest In Ultragenyx

Details

Is Ultragenyx Stock a good investment?

Details

What is Ultragenyx's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(6.22)

Revenue Per Share

6.015

Quarterly Revenue Growth

0.423

Return On Assets

(0.24)

Return On Equity

(2.90)

The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ultragenyx Stock Based Compensation vs Exchange Rate Changes Analysis

Stock Based Compensation vs Exchange Rate Changes

Stock Based Compensation vs Exchange Rate Changes Correlation Analysis

Correlation Coefficient

Stock Based Compensation

Exchange Rate Changes

Ultragenyx fundamental ratios Correlations

Ultragenyx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ultragenyx fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Non Current Liabilities Total	+ 1.0	Other Liab
Total Liab	+ 1.0	Other Liab
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Total Liab	+ 1.0	Non Current Liabilities Total

Cash	- 0.99	Net Debt
Retained Earnings	- 0.98	Total Current Liabilities
Retained Earnings	- 0.98	Other Current Liab
Total Liab	- 0.97	Retained Earnings
Other Stockholder Equity	- 0.97	Retained Earnings
Non Current Assets Total	- 0.97	Retained Earnings